Rivfloza
Drug
Novo Nordisk AS
Total Payments
$1.1M
Transactions
984
Doctors
634
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.1M | 984 | 634 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $993,684 | 92 | 92.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,836 | 10 | 3.8% |
| Food and Beverage | $23,044 | 847 | 2.1% |
| Consulting Fee | $10,138 | 14 | 0.9% |
| Travel and Lodging | $9,454 | 20 | 0.9% |
| Space rental or facility fees (teaching hospital only) | $3,500 | 1 | 0.3% |
Payments by Type
Research
$993,684
92 transactions
General
$86,971
892 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DCR-PHXC-301 | Novo Nordisk AS | $637,689 | 0 |
| DCR-PHXC-204 | Novo Nordisk AS | $168,613 | 0 |
| DCR-PHXC-502 | Novo Nordisk AS | $104,877 | 0 |
| DCR-PHXC-203 | Novo Nordisk AS | $82,506 | 0 |
Top Doctors Receiving Payments for Rivfloza
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Provo, UT | $997,208 | 94 |
| , M.D | Pediatric Nephrology | Cincinnati, OH | $24,339 | 20 |
| , M.D | Urology | New Brunswick, NJ | $22,268 | 20 |
| , M.D., PH.D | Urology | Nashville, TN | $5,928 | 4 |
| , M.D | Urology | Voorhees, NJ | $1,488 | 2 |
| , D.O | Pediatric Urology | Birmingham, AL | $1,488 | 2 |
| , M.D | Urology | East Setauket, NY | $1,488 | 2 |
| , MD | Urology | San Diego, CA | $1,488 | 2 |
| , M.D | Urology | San Francisco, CA | $1,488 | 2 |
| , MD | Urology | Stony Brook, NY | $1,350 | 2 |
| Brianna Czaikowski | Family | Marshfield, WI | $230.41 | 3 |
| , M.D. MPH | Student in an Organized Health Care Education/Training Program | Cincinnati, OH | $181.26 | 2 |
| , MD | Surgery | Bakersfield, CA | $171.62 | 2 |
| , M.D | Nephrology | San Francisco, CA | $164.64 | 3 |
| , M.D | Nephrology | Rochester, MN | $155.97 | 2 |
| Lauren Winters | Acute Care | Iowa Colony, TX | $149.93 | 6 |
| , M.D | Nephrology | New York, NY | $139.86 | 2 |
| , MD | Nephrology | Cleveland, OH | $134.40 | 2 |
| , NP | Family | Cleveland, OH | $134.40 | 2 |
| , APNP, CPNP | Pediatrics | Milwaukee, WI | $125.00 | 1 |
| , AGACNP-BC | Acute Care | Houston, TX | $124.99 | 5 |
| Scott Johnson | Urology | Milwaukee, WI | $124.04 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Milwaukee, WI | $124.03 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Milwaukee, WI | $124.03 | 1 |
| , NP | Family | Baton Rouge, LA | $122.79 | 1 |
Ad
Manufacturing Companies
- Novo Nordisk AS $993,684
- Novo Nordisk Inc $86,971
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 634
- Transactions 984
About Rivfloza
Rivfloza is a drug associated with $1.1M in payments to 634 healthcare providers, recorded across 984 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk AS.
Payment data is available from 2024 to 2024. In 2024, $1.1M was paid across 984 transactions to 634 doctors.
The most common payment nature for Rivfloza is "Unspecified" ($993,684, 92.0% of total).
Rivfloza is associated with 4 research studies, including "DCR-PHXC-301" ($637,689).